Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine.
Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine by making it cost-effective, accessible, and actionable for our patients. Phosphorus’s suite of clinical-grade genomics tests use next-generation sequencing (NGS) and are available to patients through healthcare providers, hospitals, and directly to consumers through its website. The Phosphorus laboratory is CLIA and CAP certified and licensed for testing in all 50 states.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 13, 2020 | Series Unknown | $7.99M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaingels | — | Series Unknown |